Management of hypercholesterolemia

被引:45
作者
Illingworth, R [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Med, Div Endocrinol Diabet & Clin Nutr, Portland, OR 97201 USA
关键词
D O I
10.1016/S0025-7125(05)70205-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article examines the clinical trial data supporting diet and drug therapy in adult patients with different lipoprotein disorders and discusses therapeutic approaches, with a focus on the reduction of plasma concentrations of LDL cholesterol. Patients who could benefit from lipid-lowering therapy should be effectively treated and followed to ensure long-term compliance, efficacy, and safety.
引用
收藏
页码:23 / +
页数:21
相关论文
共 72 条
[71]   Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation [J].
White, CM .
JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (02) :111-118
[72]  
Wood D, 1998, EUR HEART J, V19, P1434